Sort   by:  
 Page size 
TranscriptomicsGene expression profiling of MDA231, BT549, and SUM159PT cells after selumetinib treatment or DUSP4 siRNA knockdown
MDA231, BT549, and SUM159PT basal-like breast cancer cell lines were transfected with non-targeting siRNA (siCONTROL), siRNA targeting DUSP4 (siDUSP4), or siCONTROL + 4 or 24 hr of 1uM selumetinib. Cells were harvested at 96 hr post-siRNA transfection. Data were Log2 RMA normalized. We sought to i...
ORGANISM(S): Homo sapiens 
2013-09-03 | E-GEOD-41816 | biostudies-arrayexpress
GenomicsSelumetinib
Selumetinib
PRJNA712989 | ENA
GenomicsRNA sequencing analysis of selumetinib-resistant CRC cells lines
RNA sequencing analysis of selumetinib-resistant CRC cells lines
PRJNA521036 | ENA
GenomicsCopy number analysis of selumetinib-resistant CRC cells lines
Copy number analysis of selumetinib-resistant CRC cells lines
PRJNA521709 | ENA
GenomicsSelumetinib in adults with NF1 and inoperable plexiform neurofibroma
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma
PRJNA1162564 | ENA
GenomicsGene expression profiling during treatment of COLO205 cells with selumetinib
Gene expression profiling during treatment of COLO205 cells with selumetinib
PRJNA712993 | ENA
GenomicsGene expression profiling during treatment of HT29 cells with selumetinib
Gene expression profiling during treatment of HT29 cells with selumetinib
PRJNA762233 | ENA
GenomicsEpigenetic and genetic change through cell cycling under selumetinib treatment
Epigenetic and genetic change through cell cycling under selumetinib treatment
PRJNA877852 | ENA
UnknownA randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas.
Not available
S-EPMC4430716 | biostudies-literature
UnknownClinical Pharmacokinetics and Pharmacodynamics of Selumetinib.
Not available
S-EPMC7935771 | biostudies-literature
Sort   by:  
 Page size